Sara Harrysson

About me
Publications
CV
Public outreach and news

About me

I am a board certified specialist in Hematology working part time as a
clinician at the Hematology department at Karolinska University Hospital in
Solna. In the clinic I see mainly patients with different types of lymphoma
and acute lymphoblastic leukemia. I defended my thesis with the title: "
Diffuse large B-cell lymphoma: population-based studies of relapse and
cardiac complications in March 2023.
PhD Karolinska Institutet 2023
Specialist in Hematology 2018
Research School for Clinicians in Epidemiology 2015-2017
MD Karolinska Institutet 2007

Research

My research focus on the most common aggressive lymphoma type
Diffuse large
B-cell lymphoma (DLBCL). Based on data from the Swedish Lymphoma register I
investigate survival and risk of relapse of DLBCL as well as outcome for the
relapse patients. I also investigate timing and risk of cardiovascular events
after a DLBCL diagnosis.

Articles

Article: LEUKEMIA AND LYMPHOMA. 2024;65(4):534-537
Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy
Harrysson S; Eloranta S; Ekberg S; Enblad G; Andersson P-O; Sonnevi K; Ljungqvist M; Sander B; Jerkeman M; Smedby KE
Article: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(35):5376-5387
High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma
Lewis KL; Jakobsen LH; Villa D; Smedby KE; Savage KJ; Eyre TA; Cwynarski K; Bishton MJ; Fox CP; Hawkes EA; Maurer MJ; El-Galaly TC; Cheah CY
Article: BMJ OPEN. 2023;13(12):e078023
ProFertil study protocol for the investigation of gonadotropin-releasing hormone agonists (GnRHa) during chemotherapy aiming at fertility protection of young women and teenagers with cancer in Sweden-a phase III randomised double-blinded placebo-controlled study
Rodriguez-Wallberg KA; Nilsson HP; Bergh J; Malmros J; Ljungman P; Foukakis T; Stragliotto CL; Friman EI; Linderholm B; Valachis A; Andersson A; Harrysson S; Vennstrom L; Frisk P; Moerse H; Eloranta S
Article: BRITISH JOURNAL OF CANCER. 2022;127(9):1642-1649
Patient trajectories after diagnosis of diffuse large B-cell lymphoma-a multistate modelling approach to estimate the chance of lasting remission
Ekberg S; Crowther M; Harrysson S; Jerkeman M; Smedby KE; Eloranta S
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2022;198(2):267-277
Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients
Harrysson S; Eloranta S; Ekberg S; Enblad G; El-Galaly TC; Sander B; Sonnevi K; Andersson P-O; Jerkeman M; Smedby KE
Article: JOURNAL OF INTERNAL MEDICINE. 2021;290(5):1048-1060
Myocardial infarction in diffuse large B-cell lymphoma patients - a population-based matched cohort study
Ekberg S; Harrysson S; Jernberg T; Szummer K; Andersson P-O; Jerkeman M; Smedby KE; Eloranta S
Article: EJHAEM. 2021;2(4):774-784
Excellent survival after R-Hyper-CVAD in hospitalized patients with high-risk large B-cell lymphoma: The Karolinska experience
Sonnevi K; Ljungqvist M; Joelsson JK; Harrysson S; Wasterlid T; Bernell P; Wahlin BE
Article: BLOOD CANCER JOURNAL. 2021;11(1):9
Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden
Harrysson S; Eloranta S; Ekberg S; Enblad G; Jerkeman M; Wahlin BE; Andersson P-O; Smedby KE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;192(1):75-81
Survival of very elderly patients with diffuse large B-cell lymphoma according to treatment intensity in the immunochemotherapy era: a Swedish Lymphoma Register study
Sonnevi K; Wasterlid T; Melen CM; Harrysson S; Smedby KE; Wahlin BE
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2020;95(7):740-748
Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma
Wasterlid T; Harrysson S; Andersson TM-L; Ekberg S; Enblad G; Andersson P-O; Jerkeman M; Eloranta S; Smedby KE
Article: BIOMEDICINES. 2020;8(6):E170-170
ROR1 is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells
Ghaderi A; Daneshmanesh AH; Moshfegh A; Kokhaei P; Vagberg J; Schultz J; Olin T; Harrysson S; Smedby KE; Drakos E; Rassidakis GZ; Osterborg A; Mellstedt H; Hojjat-Farsangi M

All other publications

Thesis / dissertation: 2023
Diffuse large B-cell lymphoma : population-based studies of relapse and cardiac complications
Harrysson, Sara

Employments

Affiliated to Research, Department of Medicine, Karolinska Institutet, 2023-2025

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Medicine, Solna, Karolinska Institutet, 2023
University Medical Degree, Karolinska Institutet, 2007

About me

Research

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI